Is Corrosive Groundwater Leaching Lead Into Your Well Water?

Connecticut is one of 11 states with a very high prevalence of potentially corrosive groundwater, increasing the risk that water running out of the taps of homes with private wells might be tainted with lead, a study conducted by the U.S. Geological Survey (USGS) found. USGS researchers analyzed nearly three decades of data from more than 20,000 public and private wells nationwide and determined that between 75.3 percent and 84.9 percent of wells in Connecticut could contain corrosive groundwater. If left untreated, corrosive groundwater can leach lead and other metals in pipes en route to the tap, raising health concerns for the estimated 871,000 state residents who rely on private wells as their primary source of drinking water. In Connecticut, the state does not mandate or conduct testing of well water, instead relying on private well owners to maintain, test and treat their own wells. Many well owners are not aware of the risks of corrosion, environmental health activists say.

Brand-name Drug Choices Drive State’s High Medicare Costs

Connecticut seniors on Medicare are more likely to take sedatives for insomnia and medications for depression than their counterparts across the country, according to a new report by Dartmouth researchers. An analysis of state data in a national report by the Dartmouth Atlas Project also shows that Connecticut’s Medicare program relies heavily on brand-name drugs, versus generics, especially in wealthy towns in Fairfield County – a factor that could be contributing to the state’s ranking in the top 10 nationally in prescription drug spending per patient. Connecticut seniors spent an average of $2,795 on medications in 2010 – 45 percent higher than the lowest-spending state, Minnesota, and the highest rate in New England. The new report provides an in-depth look at how prescription drugs are used by Medicare beneficiaries, age 65 and older, in the program’s Part D drug benefit, which had 37 million enrollees in 2012. It shows wide variations in the use of both effective and risky drugs among the 306 regional health care markets across the U.S.

While the underlying health status of populations is a factor in prescription drug use, “it really does not explain the variations in drug use intensity that we observed,” said Dr. Nancy Morden, a lead author of the study.

Connecticut Hospitals Don’t Make ‘Top Performer’ List

Connecticut is the only New England state—and one of just three nationally—to have no hospitals designated as “Top Performers” by The Joint Commission, which issued an annual report gauging the performance of more than 3,300 accredited hospitals on 45 accountability measures linked to positive patient outcomes.